Drug Shortage Report for AXID
| Report ID | 17802 |
| Drug Identification Number | 00778338 |
| Brand name | AXID |
| Common or Proper name | AXID 150mg CAPS 100 |
| Company Name | PENDOPHARM DIVISION OF PHARMASCIENCE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | NIZATIDINE |
| Strength(s) | 150MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | A02BA |
| ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2017-08-09 |
| Actual start date | 2017-08-09 |
| Estimated end date | 2018-10-12 |
| Actual end date | 2018-10-25 |
| Shortage status | Resolved |
| Updated date | 2018-10-29 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.